Gibson CM, de Lemos JA, Murphy SA et al., (2001). Combination therapy with abciximab reduces angiograhically evident thrombus in acute myocardial infarction – a TIMI 14 substudy. Circulation 103,2550–2554.
Carrick D, Oldroyd KG, McEntegart M, et al., (2014):A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol; 63:2088–2098.
, MD, Lingxin Pan
, MD, Bin Zhang
, MD et al., (2017):
Deferred Versus Immediate Stenting in Patients with ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis – Journal of the American Heart Association; Vol. 6, No. 3
O’Gara PT, Kushner FG, Ascheim DD, et al., (2013): ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol; 61:485–510.
Fokkema ML, Vlaar PJ, Svilaas T, et al., (2009): Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J; 30:908–915.
Ke D, Zhong W, Fan L, et al., (2012): Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden. Coron Artery Dis; 23:497–506.
Pascal J, Veugeois A, Slama M, et al., (2016): Delayed stenting for ST-elevation acute myocardial infarction in daily practice: a single center experience. Can J Cardiol; 32:988–995.
Kelbæk H, Høfsten DE, Køber L, et al., (2016): Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial. Lancet; 387:2199–2206.
Belle L, Motreff P, Mangin L, et al., (2016):Comparison of immediate with delayed stenting using the minimalist immediate mechanical intervention approach in acute ST-segment-elevation myocardial infarction: the MIMI Study. Circ Cardiovasc Interv.; 9:e003388.
Rao AK, Pratt C, Berke A, et al., (1988): Thrombolysis in Myocardial Infarction (TIMI) Trial—phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol; 11:1–11.
Mehran R, Rao SV, Bhatt DL, et al., (2011): Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation; 123:2736–2747.
Harbaoui B, Courand PY, Besnard C, et al., (2015): Deferred vs immediate stenting in ST elevation myocardial infarction: potential interest in selected patients. Presse Med; 44:e331–e339.
Kelbæk H, Engstrøm T, Ahtarovski KA, et al., (2013): Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study. EuroIntervention; 8:1126–1133.
Bethke A, Halvorsen S, Bøhmer E, et al., (2015): Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty). EuroIntervention; 11:518–524.
Freixa X, Belle L, Joseph L, et al., (2013): Immediate vs delayed stenting in acute myocardial infarction: a systematic review and meta-analysis. EuroIntervention; 8:1207–1216.
Zalewski J, Nycz K, Przewlocki T, et al., (2011):Evolution of myocardial perfusion during primary angioplasty in spontaneously reperfused infarct-related artery: impact on long-term clinical outcomes and left ventricular function recovery. Int J Cardiol; 147:25–31.
Lønborg J, Engstrøm T, Ahtarovski KA, et al.Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3–DEFER Substudy. J Am Coll Cardiol 2017;69:2794-804.